Analysis of new funds. Inveready and Asabys Partners with Banco Sabadell.
20/06/2018
Diego Gutiérrez
Analysis of new funds. Inveready and Asabys Partners with Banco Sabadell.

We analyse the new funds created in Spain in the biotechnology sector during the first half of 2018. In this case, we will study the company Inveready and the alliance between Asabys Partners and Banco Sabadell.

Get in touch with our experts.

We analyse the new funds created in Spain in the biotechnology sector during the first half of 2018. In this case, we will study the company Inveready and the alliance between Asabys Partners and Banco Sabadell.

Inveready

Inveready Technology Investment Group, a Catalan venture capital firm, is a venture capital firm specialising in providing value to early-stage technology companies. According to ASCRI it is one of the leading funds in Spain and in 2017 they were awarded the prize for the best asset management firm in Spain. With six investment funds. Inveready invests in technology companies with high growth potential and innovative business models. Inveready has extensive experience in different areas, with more than 80 leading portfolio companies in their respective markets.

Inveready has six investment vehicles with €92 million under management. The funds have invested in more than 80 companies since 2008.

Since we are analysing the new funds that have emerged within the biotech sector, it is worth noting that the average investment in Catalan companies belonging to this sector in 2017 was €3.4M.

With this year's fund, it would be the third investment vehicle in the biotech sector. The fund, called Biotech III, would be the Barcelona-based fund manager's ninth and would have a size of €25m.

CORPORATE FINANCE EXPERTS

Asabys Partners with Banco Sabadell

Asabys Partners, based in Barcelona, is a professional investment firm that works closely with entrepreneurs to build healthcare and innovation companies with technologies and products designed to transform people's lives and provide disruptive solutions to today's healthcare challenges. It specialises in biotech, medtech and healthcare innovation start-ups.

Asabys has recently signed a partnership with Banco Sabadell to launch its first specialised health sciences vehicle, Sabadell Asabys Health Innovation Fund, with a target size of €60M to invest in early stage drug development companies, medical devices and digital applications in Spain, the UK and Israel.

It is worth noting that Banco Sabadell's participation is proof of its continued commitment to investing in the healthcare sector, acting as a benchmark investor in this fund, along with Asabys, recently launched by Sanfeliu, former co-founder/partner of Ysios Capital.

 

Other new funds in the biotech sector

CompanyInverterCountryAmountDate
Abac TherapeuticsCaixa Capital Risk

Pontifax

Global Health Science Fund

Debiopharm Innovation Fund

 

Spain16M€15/02/2018
BDi BiotechnologyInveready

Dyadic International

Spain3,9M€4/01/2018
BionureAlta Life ScienceUSA. USA.4M€17/05/2018
ProteodesignCaixa Capital Risk

Business Angels

Spain1,7M€28/02/2018

Other posts that may interest you

https://techma.bakertilly.es/nuevos-fondos-en-marzo-arta-black-toro-nekko-benavent-trea-direct-lending/

https://techma.bakertilly.es/nuevos-fondos-febrero-nexxus-torreal-towerbrook-peninsula-providence/

https://techma.bakertilly.es/nuevos-fondos-miura-inveready-capzanine/

If you are looking for investors, want to buy or sell your company or finance your R&D&I project, contact our Corporate Finance experts.

If you are looking for investors, want to buy or sell your company or finance your R&D&I project, contact our Corporate Finance experts.

Lastest news

Latest transactions in the Cybersecurity sector

El sector de la ciberseguridad ha sido testigo de una importante oleada de adquisiciones estratégicas en los últimos meses, a medida que las empresas tratan de ampliar sus capacidades y hacer frente a la creciente demanda de una sólida protección digital. Cinco...

Latest transactions in the Consumer Software sector

El sector del Consumer software ha experimentado recientemente una dinámica oleada de adquisiciones que pone de relieve su evolución hacia la mejora de la participación de los usuarios y la ampliación de los servicios digitales. Entre las operaciones más destacadas...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42